Patient and procedural characteristics
PV isolation was successfully completed in all 1004 cases, using Carto 3
in 822 (82%), Ensite NavX in 159 (16%) and Rhythmia in 23 (2%).
Patient characteristics are shown in Table 1. Procedural characteristics
between patients with and without DHF are shown in Supplementary Table
1.